MGMT and glioblastoma: In addition, DNA methylation biomarkers are also useful for predicting cancer treatment response; for example, tumor MGMT (gene important in DNA repair) promotor hypermethylation is associated with good response to alkylating drugs and used in clinical testing in glioblastomas [17].